4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001781450-26-000002
Options or other derivatives
- PRESIDENT AND CEO acquired 480,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Bashan Dror PRESIDENT AND CEO | 2026-09-03 | Grant or award · Stock Option (Right to Buy) | +320,000 | 320,000 | D | ||
| Bashan Dror PRESIDENT AND CEO | 2026-09-03 | Grant or award · Restricted Stock Units | +160,000 | 160,000 | D | ||
Loading xslF345X06/form4-09042026_060904.xml…